ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Condition:   Neurological Cancer Intervention:   Drug: ASTX727 Sponsors:   Massachusetts General Hospital;   Astex Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials